Ruggaard & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Sell
3,219
-533
-14% -$60.2K 0.13% 93
2025
Q4
$470K Buy
3,752
+78
+2% +$9.94K 0.19% 70
2025
Q3
$492K Buy
3,674
+40
+1% +$5.25K 0.18% 68
2025
Q2
$494K Buy
3,634
+601
+20% +$79.3K 0.2% 63
2025
Q1
$402K Buy
3,033
+487
+19% +$62K 0.18% 75
2024
Q4
$288K Sell
2,546
-841
-25% -$97.2K 0.13% 92
2024
Q3
$386K Buy
3,387
+281
+9% +$30.8K 0.17% 80
2024
Q2
$323K Sell
3,106
-18
-0.6% -$1.91K 0.15% 87
2024
Q1
$355K Sell
3,124
-11
-0.4% -$1.26K 0.17% 83
2023
Q4
$345K Buy
3,135
+311
+11% +$31.1K 0.18% 76
2023
Q3
$274K Buy
2,824
+29
+1% +$3.05K 0.16% 86
2023
Q2
$305K Buy
2,795
+40
+1% +$4.26K 0.18% 81
2023
Q1
$279K Buy
+2,755
New +$291K 0.17% 83

Other funds holding ABT

Ruggaard & Associates's ABT Position: Q1 2026 in Review

Ruggaard & Associates reduced its Abbott (ABT) stake by 14% in Q1 2026, selling an estimated $60.2K and leaving 3,219 shares worth $331K. The position accounts for 0.13% of the portfolio, ranked #93.

Ruggaard & Associates first reported a position in ABT in Q1 2023 and has held it in 13 quarters since. The position peaked at $494K in Q2 2025. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Ruggaard & Associates held 3,219 shares of Abbott worth $331K as of Q1 2026.
  • Ruggaard & Associates sold 533 Abbott shares in Q1 2026, an estimated $60.2K.
  • Abbott made up 0.13% of Ruggaard & Associates's portfolio in Q1 2026, its #93 holding.
  • Ruggaard & Associates first reported a position in Abbott in Q1 2023 and has held it in 13 quarters since.
  • Ruggaard & Associates's Abbott position peaked at $494K in Q2 2025.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Ruggaard & Associates's 13F filing for Q1 2026, filed 26 May 2026.